From: ISO 10993 biological evaluation of novel hemostatic powder – 4SEAL®
Group | GGT* | Glucose | K | P | Na | bilirubin | Total protein | Triglycerides | Blood urea nitrogen |
---|---|---|---|---|---|---|---|---|---|
[U/L] | [mg/dL] | [mmol/L] | [mg/dL] | [mmol/L] | [mg/dL] | [g/dL] | [mg/dL] | [mg/dL] | |
Negative control - female | * | 242.20 | 4.06 | 6.08 | 141.80 | 0.18 | 5.64 | 182.20 | 22.74 |
4SEAL® - female | * | 247.20 | 4.44 | 6.30 | 141.00 | 0.24 | 5.48 | 101.40 | 18.88 |
Negative control – male | * | 324.60 | 5.32 | 7.70 | 138.40 | 0.22 | 5.32 | 99.60 | 18.50 |
4SEAL® - male | * | 333.60 | 5.14 | 7.72 | 136.00 | 0.18 | 5.28 | 146.00 | 26.50 |